Stay updated on PAC-1 in Refractory Metastatic Kidney Cancer Clinical Trial

Sign up to get notified when there's something new on the PAC-1 in Refractory Metastatic Kidney Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the PAC-1 in Refractory Metastatic Kidney Cancer Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The record describes a pilot study of PAC-1 and nivolumab for metastatic renal cell carcinoma. It shows the study as withdrawn due to funding issues, with actual enrollment of 0.
    Difference
    43%
    Check dated 2026-11-08T14:34:40.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The footer revision changed from v3.7.2 to v3.8.0; the page still shows a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-01T15:48:59.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    A site-wide notice announces updates about NIH websites and says some content may use “Super Intelligence” (SI) instead of “Artificial Intelligence” (AI) during the transition.
    Difference
    1%
    Check dated 2026-10-25T15:33:21.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-18T22:11:56.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The site footer’s revision number changed from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-11T21:53:45.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, replacing the study record content. This indicates access to the study record is blocked.
    Difference
    17%
    Check dated 2026-09-20T22:14:04.000Z thumbnail image

Stay in the know with updates to PAC-1 in Refractory Metastatic Kidney Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the PAC-1 in Refractory Metastatic Kidney Cancer Clinical Trial page.